Boai NKY Pharmaceuticals Ltd. is a prominent Chinese pharmaceutical company, publicly traded on the Shenzhen Stock Exchange under the stock code 300109. Established in 2001, it specializes in the development and manufacture of pharmaceutical excipients, particularly Povidone (PVP) and its derivatives, including Copovidone and Crospovidone. Boai NKY is recognized as the third-largest global manufacturer of PVP, which is widely used in the pharmaceutical industry as a binder, stabilizer, and film-forming agent.